Evidence map›Paper›PMID 21240276›Full record

ArticleNature genetics2011

Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.

Gerry P Crossan, Louise van der Weyden, Ivan V Rosado, Frederic Langevin, Pierre-Henri L Gaillard, Rebecca E McIntyre, Sanger Mouse Genetics Project, Ferdia Gallagher, Mikko I Kettunen, David Y Lewis and 4 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed, 218 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Double jeopardy: howFrontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cell genomics · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability.Critical reviews in biochemistry and molecular biology · 2021
    Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Gerry P CrossanMedical Research Council, Laboratory of Molecular Biology, Cambridge, UK.
Louise van der Weyden
Ivan V Rosado
Frederic Langevin
Pierre-Henri L Gaillard
Rebecca E McIntyre
Sanger Mouse Genetics Project
Ferdia Gallagher
Mikko I Kettunen
David Y Lewis
Kevin Brindle
Mark J Arends
David J Adams
Ketan J Patel
MRC Laboratory of Molecular Biology · GBCancer Research UK Cambridge Center · GBCentre National de la Recherche Scientifique · FRUniversity of Cambridge · GBWellcome Sanger Institute · GB

Funding

Cancer Research UK 12401Cancer Research UK A11073Cancer Research UK A11376Cancer Research UK A12401Cancer Research UK A8449Medical Research Council MC_U105178811Medical Research Council U.1051.03.009(78811)Wellcome Trust 098051
6 · The paper itself

Abstract

The evolutionarily conserved SLX4 protein, a key regulator of nucleases, is critical for DNA damage response. SLX4 nuclease complexes mediate repair during replication and can also resolve Holliday junctions formed during homologous recombination. Here we describe the phenotype of the Btbd12 knockout mouse, the mouse ortholog of SLX4, which recapitulates many key features of the human genetic illness Fanconi anemia. Btbd12-deficient animals are born at sub-Mendelian ratios, have greatly reduced fertility, are developmentally compromised and are prone to blood cytopenias. Btbd12(-/-) cells prematurely senesce, spontaneously accumulate damaged chromosomes and are particularly sensitive to DNA crosslinking agents. Genetic complementation reveals a crucial requirement for Btbd12 (also known as Slx4) to interact with the structure-specific endonuclease Xpf-Ercc1 to promote crosslink repair. The Btbd12 knockout mouse therefore establishes a disease model for Fanconi anemia and genetically links a regulator of nuclease incision complexes to the Fanconi anemia DNA crosslink repair pathway.

Indexed as

AnimalsCellular SenescenceCross-Linking ReagentsDNA DamageFanconi AnemiaFemaleFibroblastsGenetic Complementation TestHematopoietic Stem CellsHumansMagnetic Resonance ImagingMaleMiceMice, KnockoutRecombinasesCross-Linking ReagentsRecombinasesSlx4 protein, mouse

Identifiers

PMID21240276
PMCPMC3624090
OpenAlexW2007988428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.